Imagin Molecular Corporation is dedicated to business opportunities in the nuclear medicine field with its primary focus in positron emission tomography (PET). PET is an advanced medical diagnostic imaging procedure used by physicians in the detection of certain cancers, coronary disease and neurological disorders.

Imagin Molecular is a publicly traded Delaware corporation on the OTCBB under the symbol IMGM. Imagin Molecular is a holding company actively engaged in businesses such as nuclear medicine device manufacturing, coronary artery disease reversal and prevention molecular imaging centers with hospital joint ventures.

Currently Imagin Molecular is the parent of three wholly owned operating subsidiaries.

1. Imagin Nuclear Partners

Imagin Nuclear Partners is a full-service joint venture molecular imaging partner that will own, operate and administer out-patient medical diagnostic imaging centers that utilizes PET and PET/CT scanning equipment. Imagin Nuclear Partners specializes in using evidence based bioinformatics specifically positioned in the market to provide the maximal cost-effective benefit to the Company’s joint venture partner and community.

Imagin Nuclear Partners currently operates a PET center within Beth Israel Hospital in New York. Imagin Nuclear Partners uses the Positron HZL-R cardiac specific imaging camera from Positron Corporation.

Imagin Nuclear Partners was formed to provide PET and related technical and educational services to diagnose and treat patients with coronary artery disease and who are at risk of developing coronary heart disease. Corporation is headquartered in Niagara Falls, New York.

2. Positron Acquisition Corporation

Positron Acquisition Corporation was formed for the sole purpose of holding securities in Positron Corporation (www.positron.com) that were acquired in conjunction with a share exchange with Imagin Diagnostic Centres of Canada. Positron Acquisition Corporation currently holds 70,400,000 common shares of Positron Corporation. Imagin Molecular Corporation acquired this position to add value to its portfolio of PET businesses. Positron's leading cardiac PET software and device provides the complete solution for Imagin Molecular Corporation’s CAD reversal and prevention centers plan. Positron Corporation’s superior technology combined with the most economic camera and expertise is the total solution for Imagin Molecular Corporation and any PET facility.

3. Cipher Multimedia, Inc.

Cipher Multimedia is a new Media Marketing and Distribution Solution Company that provides a Distribution Solution for publishers of digital content. Cipher Multimedia will develop marketing campaigns that will assist Imagin, Positron Corporation and other companies market their products and will continue to provide publishers a distribution solution for digital content. Imagin Molecular Corporation is in the process of spinning this company off through a stock dividend to its shareholders.